News tagged with blood count

Beleodaq approved for aggressive non-hodgkin lymphoma

(HealthDay)—Beleodaq (belinostat) has been approved by the U.S. Food and Drug Administration to treat peripheral T-Cell lymphoma (PTCL), a rare and aggressive form of non-Hodgkin lymphoma (cancer of the lymph nodes).

Jul 03, 2014
popularity0 comments 0

Subscribe to rss feed